The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
New assay technologies for high-throughput screening
Abstract
The use of high-throughput screening for early stage drug discovery imposes several constraints on the format of assays for therapeutic targets of interest. Homogeneous cell-free assays based on energy transfer, fluorescence polarization spectroscopy or fluorescence correlation spectroscopy provide the sensitivity, ease, speed and resistance to interference from test compounds needed to function in a high-throughput screening mode. Similarly, novel cell-based assays are now being adapted for high-throughput screening, providing for in situ analysis of a variety of biological targets. Finally, recent advances in assay miniaturization mark a transition to ultra high-throughput screening, ensuring that identification of lead compounds will not be the rate-limiting step in finding new drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Fluorescent indicators for Ca2+based on green fluorescent proteins and calmodulin
Miyawaki, A., Llopis, J. L., Heim, R., McCaffery, J. M., Adams, J. A., Ikura, M., & Tsien, R. Y. (1997) · Nature · doi:10.1038/42264 · Cited by 3,250
Heim, R., & Tsien, R. Y. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00450-5 · Cited by 1,490
Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity
Hill, C. S., & Treisman, R. (1995) · Cell · doi:10.1016/0092-8674(95)90403-4 · Cited by 1,012
Sorting single molecules: application to diagnostics and evolutionary biotechnology.
Eigen, M., & Rigler, R. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5740 · Cited by 961
Zlokarnik, G., Negulescu, P. A., Knapp, T. E., Mere, L., Burres, N. S., Feng, L., Whitney, M. A., Roemer, K., & Tsien, R. Y. (1998) · Science · doi:10.1126/science.279.5347.84 · Cited by 691
Lenormand, P., Sardet, C., Pagès, G., L’Allemain, G., Brunet, A., & Pouysségur, J. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.5.1079 · Cited by 660
Chemokine receptors: Gateways to inflammation and infection
Premack, B. A., & Schall, T. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1174 · Cited by 630
Complex formation between RAS and RAF and other protein kinases.
Aelst, L. V., Barr, M. M., Marcus, S., Polverino, A. J., & Wigler, M. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6213 · Cited by 620
A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation
Barak, L. S., Ferguson, S. S. G., Zhang, J., & Caron, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27497 · Cited by 428
Rare earth cryptates and homogeneous fluoroimmunoassays with human sera
Mathis, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.9.1953 · Cited by 393
Cited by
Sorted by citations
Items 101–154 of 154
Techniques used for the discovery of therapeutic compounds: The case of SARS
Chen, S., Chen, L., Chen, K., Shen, X., & Jiang, H. (2006) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2006.09.005 · Cited by 9
“Cell-based assay systems (thoroughly reviewed in [38] ) have significant advantages over in vitro assays.”
BackgroundAnalysis of High-Dimensional Structure-Activity Screening Datasets Using the Optimal Bit String Tree
Zhang, K., Hughes‐Oliver, J. M., & Young, S. S. (2013) · Technometrics · doi:10.1080/00401706.2012.760489 · Cited by 8
“With the development of high-throughput screening (HTS) techniques, large structural-biological activity datasets are now the norm rather than the exception (Sittampalam, Kahl, and Janzen 1997; Silverman, Campbell, and Broach 1998).”
BackgroundQiu, C., Fang, Z. D., Zhao, L., He, W., Yang, Z., Liu, C., & Guo, K. (2019) · Reaction Chemistry & Engineering · doi:10.1039/c8re00327k · Cited by 8
APPLICATIONS OF NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY TO ANTICANCER DRUG DISCOVERY
Powers, R., & Siegel, M. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012088561-9/50006-5 · Cited by 8
Ettlin, R. A., & Hodel, C. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00257-x · Cited by 8
Hempel, R., Wirsching, F., Schober, A., & Schwienhorst, A. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5322 · Cited by 8
Expression of Cre recombinase as a reporter of signal transduction in mammalian cells
Mattheakis, L. C., Olivan, S. E., Dias, J., & Northrop, J. P. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80130-6 · Cited by 8
Kumar, B., Chawla, P. A., & Chawla, V. (2022) · Springer eBooks · doi:10.1007/978-981-16-5180-9_16 · Cited by 7
From target identification to drug screening assays for neurodegenerative diseases
Zuccato, C., Tartari, M., Goffredo, D., Cattaneo, E. F., & Rigamonti, D. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.03.010 · Cited by 9
A High-Throughput Mammalian Cell-Based Transient Transfection Assay
Noonan, D. J., Henry, K. W., & Twaroski, M. L. (2004) · Humana Press eBooks · doi:10.1385/1-59259-816-1:051 · Cited by 7
Pharmacological Screening: Drug Discovery
Nemmani, K. V. S. (2021) · Springer eBooks · doi:10.1007/978-981-15-5534-3_7 · Cited by 6
Clinical Trials in Cancer and Pharmacogenomics: A Critical Evaluation
Băianu, I. C. (2012) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000109 · Cited by 5
“ZD 1839 (Iressa) blocks EGFR; ZD1839 inhibits autophosphorylation, and resulted in complete regression in some xenograft tumors [82,245] when used either in conjunction with cytotoxic drugs such as doxorubicin, or in combination with radiation; Iressa inhibits the Ras/MAP kinase and STAT-3 transcription factors, in ma…”
BackgroundExploring the Relationships between Structure and Antimicrobial Potency of Quinolinequinones
Kara, E. M., Bayrak, N., Yıldız, M., Yıldırım, H., & Tuyun, A. F. (2022) · Antibiotics · doi:10.3390/antibiotics11101397 · Cited by 6
“Despite the growing demand for new therapeutic compounds from natural sources, their isolation, scale-up, and structure elucidation remain intensive processes [10,11].”
BackgroundC, I. (2011) · InTech eBooks · doi:10.5772/18781 · Cited by 4
Firempong, C. K., Cao, X., Tong, S., Yu, J., & Xu, X. (2015) · RSC Advances · doi:10.1039/c5ra08322b · Cited by 5
Pharmaceutical Usefulness of Biopharmaceutics Classification System: Overview and New Trend
Youn, Y.-S., Lee, J., Jeong, S.-H., Shin, B.-S., & Park, E. (2010) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2010.40.s.001 · Cited by 5
Biotechnology and Applied Microbiology
ROSENBERG, E. B. (2013) · Springer eBooks · doi:10.1007/978-3-642-30194-0_13 · Cited by 5
Effective Strategy of Drug Discovery from Marine Ecosystem
Porzani, S. J., & Nowruzi, B. (2023) · Marine ecology · doi:10.2174/9789815051995123030012 · Cited by 4
Studying Noncovalent Small Molecule Interactions with Protein and RNA Targets by Mass Spectrometry
Loo, J. A., Thanabal, V., & Mei, H. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-719-2_5 · Cited by 4
Polymer-Supported Reagents and Scavengers in Synthesis
Ley, S. V., Baxendale, I. R., & Myers, R. M. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00108-5 · Cited by 4
Flaumenhaft, R. C. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00080-8 · Cited by 3
Development of a chemical screening system using aqueorin-fused protein
Suzuki, M., Furukawa, S., Kuramori, C., Sawa, C., Kabe, Y., Nakamura, M., Sawada, J.-I., Yamaguchi, Y., Sakamoto, S., Inouye, S., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.107 · Cited by 3
Cancer Clinical Trials Optimization and PharmacogenomicsPreprint
Băianu, I. C. (2012) · Nature Precedings · doi:10.1038/npre.2012.7046.1 · Cited by 3
Selective Optimization of Side Activities: An Alternative and Promising Strategy for Lead Generation
Handler, N., Wolkerstorfer, A., & Buschmann, H. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch09 · Cited by 3
Farahani, N. I., Lin, L. D., Nazir, S., Naderi, A., Rokos, L., McIntosh, A. R., & Julian, L. M. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1478572 · Cited by 4
New Advances in Cell Adhesion Technology
Carnazza, S. (2008) · Springer eBooks · doi:10.1007/978-3-540-70946-6_3 · Cited by 2
Lim, B. S., Foo, T. T., Chong, W. S., & Puah, C. M. (2007) · Annual Conference of the IEEE Industrial Electronics Society (IECON) · doi:10.1109/iecon.2007.4460189 · Cited by 2
“Design considerations for the integration of such a micro level sensor and micro-fluidic dispenser must be factored early into the design of the automated workstation, so as to ensure cell viability and system reliability [5].”
BackgroundCurrent Methodologies for Membrane Permeability Assessment
Shin, B.-S., Youn, Y.-S., Jeong, S.-H., Park, E., Lee, M.-H., & Yoo, S.-D. (2010) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2010.40.s.019 · Cited by 2
“Owing to the combinatorial chemistry and automated high throughput screening, it is common to screen 100,000 compounds in a 1- to 6-month period (Broach and Thorner, 1996; Silverman et al., 1998), and this makes it possible to generate thousands of therapeutically active compounds in a short time period.”
BackgroundNeurochemical bases of visceral nociception: Mathematical model
Miftahof, R. N., & Рустэмович, А. Н. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.07.022 · Cited by 1
Robotic Implementation of Assays: Tissue-Nonspecific Alkaline Phosphatase (TNAP) Case Study
Chung, T. D. Y. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-562-0_4 · Cited by 1
New Insights into the Discovery of Novel Drugs to Treat Human Pulmonary Adenocarcinoma
Wang, Y., Zhang, H., Chen, Y., & Wang, L. (2019) · Journal of Cancer Therapy · doi:10.4236/jct.2019.102014 · Cited by 1
“HTS is the process to study the effects of large numbers of samples on the biological activity of targets such as proteins, enzymes, ion channels, receptors [25] [26].”
BackgroundWong, T. S., & Tee, K. L. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-56898-6_7 · Cited by 1
Breinbauer, R., Hillisch, A., & Waldmann, H. (2007) · Chemical biology · doi:10.1002/9783527619375.ch7a · Cited by 1
A micro-fluidic level sensing and dispensing system for large-scale stem cell experimentations
Tan, S. Y. E., Loh, E. S., Foo, T. T., Chong, W. S., Puah, C. M., & Lim, B. S. (2006) · IEEE International Conference on Emerging Technologies and Factory Automation (ETFA) · doi:10.1109/etfa.2006.355418 · Cited by 1
“Design considerations for the integration of such a micro level sensor and micro-fluidic dispenser must be factored early into the design of the automated workstation, so as to ensure cell viability and system reliability [10].”
BackgroundAutomated microinjection with integrated cell sorting, immobilization and collection
Graf, S. (2011) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006682141 · Cited by 1
“Cell-based assays / models are set to become the preferred choice of screening in drug discovery research, potentially overtaking more traditional approaches that include animal models [73, 74].”
BackgroundThe role of organic synthesis in the generation of molecular diversity
Wright, D. L., Orugunty, R. S., & Robotham, C. V. (2001) · Organic synthesis · doi:10.1016/s1047-773x(01)80005-6 · Cited by 1
New Strategies for Natural Products Lead Generation
Carter, G. T., Bernan, V. S., & Koehn, F. E. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc116
The Role of Organic Synthesis in the Generation of Molecular Diversity
Wright, D. L., Orugunty, R. S., & Robotham, C. V. (2003) · ChemInform · doi:10.1002/chin.200321260
Xu, E. Y., Ault, A., & Broach, J. R. (2008) · Journal Of Biochemical Technology
Self-citationIntroduction Strategies in Drug Discovery and Evaluation
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_1
THE IN VITRO METABOLISM OF THREE ANTICANCER DRUGS
Fan, Y. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
Synthesis of sultams and related sulfur heterocycles using the ring -closing metathesis reaction
Jiménez, M. D. S. (2007) · KU ScholarWorks (The University of Kansas)
Matter, A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_5
Dam-1 Molecular Sieve Forms, Fibers and Films
Coutinho, D. H., Madhugiri, S., & Pantano, P. (2002) · MRS Proceedings · doi:10.1557/proc-726-q9.2
From genetics and genomics to drug discovery: yeast rises to the challenge
Pulvirenti, L. (2002)
Ko, S., Lee, S., Kang, S., Ahn, G., Cha, S., & Jeon, Y. (2011) · Han-gug hae-yang ba-i-o haghoeji/Han-guk haeyang baio hakoeji · doi:10.15433/ksmb.2011.5.4.033
“High throughput screening (HTS) is an instrument for quick screening and a large number of materials are automatically tested, for activity as activators and inhibitors of a particular biological target [18].”
BackgroundZhang, K., & Hughes‐Oliver, J. M. (2003) · NCSU Libraries Repository (North Carolina State University Libraries)
Introduction Strategies in drug discovery and evaluation1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_1
Davis, J. R., & White, M. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm1200
Biotechnology and Applied Microbiology
ROSENBERG, E. B. (2006) · Springer eBooks · doi:10.1007/0-387-30741-9_12
Wong, T. S., & Tee, K. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-32826-8_7
BindingDB (2009) · UC San Diego · doi:10.7270/q289154f
Metadata
- Authors
- Silverman, L., Campbell, R., & Broach, J. R.
- Affiliations
- Princeton University (US)
- Corresponding author
- Broach, James R
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 1998-06
- Volume
- 2
- Issue
- 3
- Pages
- 397-403
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2092399057
- Cited by
- 151
- References
- 55
- Citations by year
- 2025: 2 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 2 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- high-throughput screening, fluorescence correlation spectroscopy, cell-based assays, assay miniaturization, ultra-high-throughput screening, lead compound identification, early drug discovery
- MeSH terms
- Animals, Cell Line, Cell-Free System, Chemistry, Organic, Drug Evaluation, Preclinical, Energy Transfer, Mammals, Miniaturization, Spectrometry, Fluorescence, Transfection, Drug Design, Genes, Reporter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review